Health and Human Services Department Notice

2026-21525: Center for Scientific Review; Notice of Closed Meetings

Get alerted when the next rule lands

New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.

Alert me on new Health and Human Services Department rules or alert me on a subject

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

Create a free account & build one →

What this rule does

The notice announces a series of closed meetings held by the Center for Scientific Review to evaluate grant applications related to various health research topics. These meetings will be virtual and closed to the public to protect confidential trade secrets, commercial property, and personal privacy.

Plain-language description generated by AI — not the agency’s official summary, which we have not captured for this rule. Read the official text →

The rule, in full

960 words as published, October 21, 2026. View the original →

Federal Register, Volume 91 Issue 202 (Wednesday, October 21, 2026) [Federal Register Volume 91, Number 202 (Wednesday, October 21, 2026)] [Notices] [Pages 66568-66569] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2026-21525] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-24-272: Clinical and Translational Science Awards (CTSA) Program. Date: November 16-17, 2026. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Maryam Rohani, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-0987, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Mechanisms of Cancer Therapeutics. Date: November 17-18, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Michael M. Opata, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health 6701 Rockledge Drive Bethesda, MD 20892 301-594-3074, [email protected]. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Kidney Endocrine and Digestive Disorders Study Section. Date: November 17-18, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Joshua Park, Ph.D. Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-1110, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Advanced Therapeutics. Date: November 17, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Lambratu Rahman Sesay, Ph.D. Chief, Advanced Cancer Therapeutics Review Branch, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-905-8294, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Basic Cancer Immunobiology and Tumor Host Interactions. Date: November 17-18, 2026. Time: 9:30 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. [[Page 66569]] Meeting Format: Virtual Meeting. Contact Person: Jennifer Ann Sanders, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-496-3553, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Program Projects: Center Core Grants: AIDS Research Center on Mental Health and HIV/AIDS. Date: November 17, 2026. Time: 10:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Marisa Srivareerat, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-0872, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Infectious Diseases and Immunology. Date: November 17-18, 2026. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Barry J. Margulies, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-3019, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cancer Immunotherapy Development. Date: November 18-19, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Asifa Haider, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 803C, Bethesda, MD 20892, (301) 480-2190, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-RM-26-017: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03). Date: November 18-19, 2026. Time: 9:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-7912, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Training: Gastroenterology, Hepatology and Nutrition. Date: November 18, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Jian Yang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-1623, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 16, 2026. Margaret N. Vardanian, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2026-21525 Filed 10-20-26; 8:45 am] BILLING CODE 4167-05-P

Don't miss the comment window

One Click Politics alerts you on every deadline, hearing, and rule change.

See all rules with comments due soon →